XOMA Royalty (XOMA) Cash & Equivalents (2010 - 2026)

XOMA Royalty (XOMA) reported Cash & Equivalents of $85.6 million for Q1 2026, down 5.17% on a YoY basis from $90.3 million in Q1 2025, and up 3.25% sequentially from $82.9 million in Q4 2025.

XOMA Royalty (XOMA) Cash & Equivalents (2010 - 2026) Analysis & Trends

XOMA Royalty (XOMA) has 17 years of Cash & Equivalents data on file, last reported at $85.6 million in Q1 2026.

  • For the quarter ending Q1 2026, Cash & Equivalents fell 5.17% year-over-year to $85.6 million; the trailing twelve-month figure through Mar 2026 stood at $85.6 million (down 5.17% YoY), and the FY2025 full-year result was $82.9 million, down 18.44% from the prior year.
  • Cash & Equivalents grew to $85.6 million in Q1 2026, from $82.9 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $153.3 million in Q4 2023 to a low of $4.0 million in Q3 2024.
  • A 5-year average of $79.1 million and a median of $84.4 million in 2022 frame the typical range for Cash & Equivalents.
  • Peak annual rise in Cash & Equivalents reached 2457.29% in 2025, while the deepest fall reached 95.14% in 2025.
  • Tracing XOMA's Cash & Equivalents over 5 years: stood at $78.3 million in 2022, then jumped by 95.81% to $153.3 million in 2023, then plunged by 33.69% to $101.7 million in 2024, then dropped by 18.44% to $82.9 million in 2025, then rose by 3.25% to $85.6 million in 2026.
  • Business Quant data shows XOMA's Cash & Equivalents at $85.6 million in Q1 2026, $82.9 million in Q4 2025, and $102.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Oculis Holding AG 67,583.17 Bn 67,582.89 Bn - 82.45 Mn
2 Nanobiotix 1,947.22 Bn 1,947.15 Bn - 61.40 Mn
3 Akari Therapeutics 1,132.35 Bn 1,132.35 Bn - 2.83 Mn
4 BeOne Medicines 473.21 Bn 468.42 Bn 1.35 Bn 4.79 Bn
5 Vertex Pharmaceuticals 123.29 Bn 116.04 Bn 2.59 Bn 5.49 Bn
6 Regeneron Pharmaceuticals 70.05 Bn 61.29 Bn 3.31 Bn 2.96 Bn
7 Belite Bio 63.09 Bn 63.09 Bn - -
8 Argenx Se 56.63 Bn 51.45 Bn 1.41 Bn 3.58 Bn
9 Revolution Medicines 37.79 Bn 37.79 Bn - 440.94 Mn
10 XOMA Royalty 478.42 Mn 412.34 Mn - 85.60 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 85.60 Mn
Dec 31, 2025 82.91 Mn
Sep 17, 2025 102.75 Mn
Jun 30, 2025 6.99 Mn
Mar 31, 2025 90.27 Mn
Dec 31, 2024 101.65 Mn
Sep 30, 2024 4.02 Mn
Jun 30, 2024 143.90 Mn
Mar 31, 2024 136.20 Mn
Dec 31, 2023 153.29 Mn
Sep 30, 2023 33.47 Mn
Jun 30, 2023 31.45 Mn
Mar 31, 2023 44.30 Mn
Sep 30, 2022 78.29 Mn
Jun 30, 2022 83.18 Mn
Mar 31, 2022 87.80 Mn
Dec 31, 2021 93.33 Mn
Sep 30, 2021 68.76 Mn
Jun 30, 2021 78.95 Mn
Mar 31, 2021 67.81 Mn